Openevidence was founded in 2022 by daniel nadler, a harvard ph.d And former founder of kensho, a financial analytics firm acquired by s&p global in 2018 Physicians treating patients with complex symptoms face a familiar challenge Sifting through thousands of medical studies to find relevant evidence whilst patients wait. The licensing agreement will allow. Openevidence is a medical information platform designed to aggregate, synthesise and visualise clinically relevant evidence
Launched from the mayo clinic platform accelerate program, it features multimedia and clinical findings from the new england journal of medicine. In this update, openevidence maintains its emphasis on grounding information in verifiable, trustworthy sources and builds on that foundation to support a wide range of physician needs. You can get the most recent evidence, data, and research Use the information to form clinical questions Examples of queries i wrote
WATCH
